Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-51509

Single-particle
4.23 Å
EMD-51509
3D View Gallery
Deposition: 09/09/2024
Map released: 12/02/2025
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-51509
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

PbuCas13b-crRNA complex, open conformation

EMD-51509

Single-particle
4.23 Å
EMD-51509
3D View Gallery
Deposition: 09/09/2024
Map released: 12/02/2025
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Segatella buccae, synthetic construct
Sample: Cas13b (cr)RNA complex

Deposition Authors: Schmelz S, Lukat P, Blankenfeldt W
AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack.
Wandera KG, Schmelz S, Migur A, Kibe A, Lukat P, Achmedov T, Caliskan N, Blankenfeldt W, Beisel CL
(2025) Mol Cell , 85 , 1162 - 1175.e7
PUBMED: 39965569
DOI: doi:10.1016/j.molcel.2025.01.020
ISSN: 1097-2765
ASTM: MOCEFL
Grant Support: